Skip to main content
BICX
OTC Industrial Applications And Services

BioCorRx Q3: Cash Down to $18,233, Going Concern Doubt Reaffirmed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.211
Mkt Cap
$6.279M
52W Low
$0.152
52W High
$1.45
52W Position info
39% above low
Off High info
85% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

BICX sits 39% above its 52-week low of $0.152 on light trading volume (0.2× avg).

Summary

BioCorRx's Q3 2026 10-Q shows cash of only $18,233, a $8.65M working capital deficit, negative quarterly revenue, and a reaffirmed going-concern warning — survival now depends on insider loans and new equity sales.


Key Events · Earnings and Guidance · BICX

  • Going Concern Doubt Reaffirmed

    As of September 30, 2026, the company held cash of $18,233 and a working capital deficit of $8,652,785; management states substantial doubt about continuing as a going concern for the next twelve months.

  • Quarterly Revenue Turns Negative

    Q3 2026 net revenue was $(40,348) versus $213,910 a year earlier, as the USWM distribution channel was wound down and prior-quarter chargeback adjustments exceeded current gross sales.

  • Cash Burn and Insider Funding

    Nine-month operating cash use was $1,052,875; during 2026 the company raised $650,000 from stock subscriptions and $404,904 of related-party promissory note advances from President Louis Lucido.

  • Material Weaknesses Disclosed

    Management identified material weaknesses in internal control over financial reporting — undocumented policies, insufficient GAAP expertise on complex transactions, and too few staff for segregation of duties — and concluded disclosure controls were not effective.


Analysis · BICX · Industrial Applications And Services

BioCorRx closed Q3 with just $18,233 of cash against a working capital deficit of $8,652,785, and management again flags substantial doubt about the company's ability to continue as a going concern for the next twelve months. Revenue for the quarter was actually negative $(40,348) as the USWM LUCEMYRA distribution channel was wound down and prior-quarter chargebacks exceeded current sales. Operations are not funding the company; insider advances — $404,904 from President Louis Lucido during 2026 — and equity sales to directors are. With a nine-month operating cash burn of $1,052,875 and no committed financing, another dilutive raise or further insider loans are the only visible paths to keep the lights on.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BICX was trading at $0.21 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $6.3M. The 52-week trading range was $0.15 to $1.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BICX - Latest Insights

BICX
Aug 14, 2026, 12:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.152
Real-time Price: $0.209313 info
Change: +$0.057313 (+38%) info
Market Cap: $6.229M info
BICX
May 15, 2026, 9:31 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.409463
Real-time Price: $0.209313 info
Change: -$0.20015 (-49%) info
Market Cap: $6.229M info
BICX
Apr 02, 2026, 3:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.400
Real-time Price: $0.209313 info
Change: -$0.190687 (-48%) info
Market Cap: $6.229M info
BICX
Mar 31, 2026, 3:04 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.400
Real-time Price: $0.209313 info
Change: -$0.190687 (-48%) info
Market Cap: $6.229M info